ATRC ATRICURE INC
2026Q1 · CUSIP 04963C209 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
222
Δ holders QoQ
-14
Breadth percentile
Top 89%
Whale holders
133
Δ whales
+8
Inst. holding value
$1.5B
New positions
35
Closed positions
49
Price momentum (1Q)
-13.6%
Put / Call
0/1
Breadth history (34 quarters)
Past Lit Events & Aftermath 7 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 16% | -2.2% | -12.4% |
| 2023Q1 | Top 15% | -1.4% | -12.5% |
| 2021Q2 | Top 12% | +6.0% | -11.8% |
| 2020Q2 | Top 11% | -5.7% | +57.8% |
| 2020Q1 | Top 5% | -17.2% | -22.0% |
| 2018Q4 | Top 10% | -10.6% | -16.4% |
| 2018Q3 | Top 10% | +1.7% | -7.8% |
Options Sentiment
Put holders
0
QoQ: 0
Call holders
1
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.10
EPS YoY
—
Revenue (TTM)
$0.6B
Revenue YoY
+15.0%
Net margin
-0.8%
ROE
-0.9%
Debt ratio
23.6%
FCF (TTM)
$54M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.